170 related articles for article (PubMed ID: 7593728)
1. Moclobemide versus fluoxetine in the treatment of inpatients with major depression.
Gattaz WF; Vogel P; Kick H; Kohnen R
J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):35S-40S. PubMed ID: 7593728
[TBL] [Abstract][Full Text] [Related]
2. Moclobemide versus fluoxetine for major depressive episodes.
Geerts S; Bruynooghe F; De Cuyper H; Demeulemeester F; Haazen L
Clin Neuropharmacol; 1994; 17 Suppl 1():S50-7. PubMed ID: 7954484
[TBL] [Abstract][Full Text] [Related]
3. Moclobemide versus fluoxetine for double depression: a randomized double-blind study.
Duarte A; Mikkelsen H; Delini-Stula A
J Psychiatr Res; 1996; 30(6):453-8. PubMed ID: 9023788
[TBL] [Abstract][Full Text] [Related]
4. A double-blind comparison of moclobemide and thioridazine versus moclobemide and placebo in the treatment of refractory, severe depression.
Stabl M; Kasas A; Blajev B; Bajetta G; Zöchling R; Holsboer-Trachsler E; Realini R; Schäublin-Loidl M
J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):41S-45S. PubMed ID: 7593730
[TBL] [Abstract][Full Text] [Related]
5. Moclobemide versus fluoxetine for a major depressive episode.
Reynaert C; Parent M; Mirel J; Janne P; Haazen L
Psychopharmacology (Berl); 1995 Mar; 118(2):183-7. PubMed ID: 7617806
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the efficacy and tolerability of moclobemide given as a single daily dose or in three divided doses per day for the treatment of patients with a major depressive episode (DSM-III-R).
Newburn G; Edwards R; Thomas H; Collier J; Fox K; Collins C; Cramer D; Reeves J; Caracatsanis A
J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):10S-15S. PubMed ID: 7593724
[TBL] [Abstract][Full Text] [Related]
7. Moclobemide versus fluoxetine in the treatment of major depressive disorder in adults.
Lapierre YD; Joffe R; McKenna K; Bland R; Kennedy S; Ingram P; Reesal R; Rickhi BG; Beauclair L; Chouinard G; Annable L
J Psychiatry Neurosci; 1997 Mar; 22(2):118-26. PubMed ID: 9074306
[TBL] [Abstract][Full Text] [Related]
8. Moclobemide and fluoxetine in the prevention of relapses following acute treatment of depression.
Lonnqvist J; Sihvo S; Syvälahti E; Sintonen H; Kiviruusu O; Pitkanen H
Acta Psychiatr Scand; 1995 Mar; 91(3):189-94. PubMed ID: 7625194
[TBL] [Abstract][Full Text] [Related]
9. Multicenter double-blind study of moclobemide and maprotiline.
Vaz-Serra A; Figueira ML; Firmino H; Albuquerque AJ; Jara JM; Pestana LC
Clin Neuropharmacol; 1994; 17 Suppl 1():S38-49. PubMed ID: 7954483
[TBL] [Abstract][Full Text] [Related]
10. Moclobemide versus clomipramine in depressed patients in general practice. A randomized, double-blind, parallel, multicenter study.
Kragh-Sørensen P; Müller B; Andersen JV; Buch D; Stage KB
J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):24S-30S. PubMed ID: 7593726
[TBL] [Abstract][Full Text] [Related]
11. A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders.
Williams R; Edwards RA; Newburn GM; Mullen R; Menkes DB; Segkar C
Int Clin Psychopharmacol; 1993 Jan; 7(3-4):155-8. PubMed ID: 8468437
[TBL] [Abstract][Full Text] [Related]
12. Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three times daily dosage schedules.
Gagiano CA; Müller FG; Berk M; Joubert PM; Brown RG; Schall R
J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):4S-9S. PubMed ID: 7593729
[TBL] [Abstract][Full Text] [Related]
13. Moclobemide twice daily in the treatment of major depressive episode: a double-blind, multicenter comparison with different three-times-daily dosage schedules.
Gagiano CA; Hart GA; Bodemer W; Schall R
Clin Neuropharmacol; 1994; 17 Suppl 1():S1-8. PubMed ID: 7954480
[TBL] [Abstract][Full Text] [Related]
14. Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial.
Guelfi JD; Payan C; Fermanian J; Pedarriosse AM; Manfredi R
Br J Psychiatry; 1992 Apr; 160():519-24. PubMed ID: 1571752
[TBL] [Abstract][Full Text] [Related]
15. Moclobemide and placebo in mild major depression: a double-blind randomized trial.
Ose E; Holm P
Psychopharmacology (Berl); 1992; 106 Suppl():S114-5. PubMed ID: 1546122
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant efficacy and quality of life in depression: a double-blind study with moclobemide and fluoxetine.
Lonnqvist J; Sintonen H; Syvälahti E; Appelberg B; Koskinen T; Mannikko T; Mehtonen OP; Naarala M; Sihvo S; Auvinen J
Acta Psychiatr Scand; 1994 Jun; 89(6):363-9. PubMed ID: 8085464
[TBL] [Abstract][Full Text] [Related]
17. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
Wheatley DP; van Moffaert M; Timmerman L; Kremer CM
J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343
[TBL] [Abstract][Full Text] [Related]
18. Moclobemide, imipramine and placebo in the treatment of major depression.
Versiani M; Nardi AE; Mundim FD; Alves A; Schmid-Burgk W
Acta Psychiatr Scand Suppl; 1990; 360():57-8. PubMed ID: 2248073
[TBL] [Abstract][Full Text] [Related]
19. Moclobemide for depression: an Australian psychiatric practice study.
Tiller JW; Johnson GF; Burrows GD
J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):31S-34S. PubMed ID: 7593727
[TBL] [Abstract][Full Text] [Related]
20. Moclobemide in continuation treatment of major depressive episodes: an open follow-up study over six months.
Gagiano CA; Müller FG; de Kock RF; Schall R
J Clin Psychopharmacol; 1995 Aug; 15(4 Suppl 2):46S-50S. PubMed ID: 7593731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
